News

Ocugen, Inc. Announces U.S. FDA Clearance Of Investigational New Drug Amendment To Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial Of OCU410ST-Modifier Gene Therapy ...
The OCU410ST Phase 2/3 pivotal confirmatory trial represents a major advancement as Ocugen's second late-stage clinical program. Ocugen plans to submit a BLA for OCU410ST in 2027 in alignment with its ...
manilatimes6d
Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST-Modifier Gene Therapy ...
Of these, 34 will receive a one-time subretinal injection of OCU410ST (200 μL at a concentration of 1.5 × 10¹¹ vector genomes/mL ... trial represents a major advancement as Ocugen's second late-stage ...
Sarepta Therapeutics' Elevidys Liver Deaths Trigger Selloff, A Contrarian Opportunity
Sarepta's stock drops on ELEVIDYS safety concerns, yet potential remains for ambulatory patients. Click here to read an ...
Business Wire5d
Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety ...
The New York Sun4d
Senate Version of ‘One Big Beautiful Bill’ Could Hand a Big Win to Second Amendment Supporters
Calling it a “generational win,” Second Amendment advocates are cheering the removal of several weapons from the National ...
PBS6d
second amendment
The landmark ruling was seen by Second Amendment supporters as a huge victory and by gun control advocates as opening… Federal judge blocks California law that would have banned carrying ...
Tampa Free Press on MSN4d
Jolly’s “Gun Grab” Declared A War On Second Amendment In Florida Governor’s Race
The Florida gubernatorial race is intensifying, with former Republican Congressman David Jolly's announced bid as a Democrat ...
MPR5d
Second Death Prompts New Safety Initiatives for DMD Gene Therapy Elevidys
A second case of acute liver failure resulting in death has been reported in nonambulatory DMD patients treated with Elevidys.